The relationship between cancer and metabolic disorders is a growing area of research. Many cancer patients experience disruptions in metabolic pathways that can affect overall health and treatment outcomes. Conditions such as obesity, diabetes, and metabolic syndrome have been shown to increase the risk of developing certain cancers and complicate cancer treatment. Cancer research is focused on understanding the metabolic changes that occur in cancer cells, such as altered glucose and lipid metabolism, and how these affect tumor progression. Researchers are also investigating metabolic therapies that could disrupt these processes to slow down or stop cancer growth, providing a new avenue for treatment in conjunction with traditional therapies.



Title : Multiplexed biosensor detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States